Johan Sandin
CEO, Co-founder
Alzecure
Sweden
Biography
Johan Sandin is a behavioral neuropharmacologist with significant international academic and industrial experience. He joined AstraZeneca in 2003 and has had scientific-, project- and senior managerial positions with responsibility for in vitro biology, in vivo pharmacology and biochemical biomarkers in the CNS research area
Research Interest
Johan Sandin research interest in vitro biology, in vivo pharmacology and biochemical biomarkers
